Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals
| Autor: | V. Moramarco, Americo Cicchetti, Angelica Carletto, Matteo Ruggeri, Silvia Coretti |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Entrepreneurship
Actuarial science performance based agreements cost-beneft analysis Markov chain Cost–benefit analysis pharmaceutical policy 05 social sciences Economics Econometrics and Finance (miscellaneous) Markov models Cost-benefit Analysis Markov model General Business Management and Accounting Empirical research 0502 economics and business pricing and reimbursement Settore SECS-P/02 - politica economica Business 050207 economics Empirical evidence 050203 business & management Pharmaceutical policy Reimbursement |
| Zdroj: | Eurasian Business Review. 9:89-101 |
| ISSN: | 2147-4281 1309-4297 |
| DOI: | 10.1007/s40821-018-0107-y |
| Popis: | The aim of this paper is to provide an empirical framework based on a discrete-time Markov chain to assess the costs and benefits of Performance Based Agreements (PBAs) for the reimbursement of pharmaceuticals. We provide an empirical testing using a case study referring to a treatment recently approved for reimbursement in Italy. The implementation of this framework is challenging for the agencies dealing with pricing and reimbursement decisions given the uncertainty associated with the treatment effectiveness and safety. On the other hand, empirical evidence shows that the awareness of the expected costs associated with different reimbursement schemes is necessary to inform decision-makers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink